{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T10:45:39Z","timestamp":1768905939429,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.4158\/ep10281.ra","type":"journal-article","created":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T21:24:48Z","timestamp":1291670688000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S1","title":["Medications That Affect Calcium"],"prefix":"10.1016","volume":"17","author":[{"given":"Mary D.","family":"Ruppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP10281.RA_bb0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcp.2010.04.002","article-title":"Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)","volume":"80","author":"Brown","year":"2010","journal-title":"Biochem Pharmacol."},{"key":"10.4158\/EP10281.RA_bb0010","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP10281.RA_bb0015","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med."},{"key":"10.4158\/EP10281.RA_bb0020","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.175.4023.768","article-title":"1,25-dihydroxycholecalciferol: A potent stimulator of bone resorption in tissue culture","volume":"175","author":"Raisz","year":"1972","journal-title":"Science."},{"key":"10.4158\/EP10281.RA_bb0025","series-title":"Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"104","article-title":"Regulation of calcium and magnesium","author":"Favus","year":"2008"},{"key":"10.4158\/EP10281.RA_bb0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7326\/0003-4819-150-2-200901200-00020","article-title":"Does furosemide have a role in the management of hypercalcemia?","volume":"150","author":"Robey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"911","key":"10.4158\/EP10281.RA_bb0035","first-page":"e9","article-title":"Incidence and clinical spectrum of thiazide-associated hypercalcemia","volume":"120","author":"Wermers","year":"2007","journal-title":"Am J Med."},{"key":"10.4158\/EP10281.RA_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpendmet0265","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism","volume":"2","author":"Silverberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.4158\/EP10281.RA_bb0045","first-page":"3458","article-title":"Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--A clinical research center study","volume":"80","author":"MeKane","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP10281.RA_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP10281.RA_bb0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: A meta-analysis","volume":"95","author":"Sankaran","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP10281.RA_bb0060","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: Mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP10281.RA_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cpt1978242219","article-title":"Salmon calcitonin in hypercalcemia","volume":"24","author":"Wisneski","year":"1978","journal-title":"Clin Pharmacol Ther."},{"key":"10.4158\/EP10281.RA_bb0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00003.2004","article-title":"Calcium absorption across epithelia","volume":"85","author":"Hoenderop","year":"2005","journal-title":"Physiol Rev."},{"key":"10.4158\/EP10281.RA_bb0075","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2215\/CJN.01451005","article-title":"Milk alkali syndrome and the dynamics of calcium homeostasis","volume":"1","author":"Felsenfeld","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.4158\/EP10281.RA_bb0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bone.2007.09.042","article-title":"Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy","volume":"42","author":"Kinoshita","year":"2008","journal-title":"Bone."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20420567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20420567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/V35X23G328173118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:52:40Z","timestamp":1761515560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20420567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":16,"alternative-id":["S1530891X20420567"],"URL":"https:\/\/doi.org\/10.4158\/ep10281.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications That Affect Calcium","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP10281.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}